Australia's largest stock trading and investment forum Australia's #1 stock forum

NTI

Click for more information

4.35%

6.6¢ neurotech international limited

Cleveland, I totally agree with all of that. I think starting...

First 2 Last

Share
Profile

Follow
tony79

184 Posts.

1

03/01/18

21:01

Post #: 30022616
Share

Originally posted by cleveland21 ↑

The trial results are due soon. It is common knowledge, from the preliminary results that we can expect a significant result for children using the Mente autism device. The stock can only re-rate at that time. They will have significant data validating their device and a $17M mc will no longer be valid. $40-50M mc will be more appropriate as they already have distribution channels in place. At $50M mc the sp will be about 60 cents. If this news hits the media, which would be likely, then they can expect strong sales in the months after the trial results are released. They may receive US FDA approval as early as Q3 2018. This is also likely as the pathway for medical devices is much, much easier than it is for drugs. If this all falls into place then a MC of $150M is very reasonable with sp of around $2. GLTAH. I think this will be one of the best stocks for 2018

Expand

Cleveland,

I totally agree with all of that. I think starting this quarter and especially at the end of calendar year, we will see a significant rerating and multiples of current share price.

Excited and not worried about current SP.

I like to earn money and in the same time help children!

Good luck to all!

Cheers, Tony

NTI Price at posting: 22.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ENV

Anteris Tech eyes US market liquidity with early-stage NASDAQ IPO paperwork

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 39 more messages in this thread...

First 2 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 6.6¢		Change -0.003(4.35%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
6.9¢	6.9¢	6.6¢	$41.72K	629.8K

Buyers (Bids)

No.	Vol.	Price($)
3	74549	6.6¢

Sellers (Offers)

Price($)	Vol.	No.
6.7¢	269492	3

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 12.25pm 25/11/2024 (20 minute delay)

NTI (ASX) Chart

SPONSORED BY